These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 30530611)
1. Recommendations on screening for breast cancer in women aged 40-74 years who are not at increased risk for breast cancer. Klarenbach S; Sims-Jones N; Lewin G; Singh H; Thériault G; Tonelli M; Doull M; Courage S; Garcia AJ; Thombs BD; CMAJ; 2018 Dec; 190(49):E1441-E1451. PubMed ID: 30530611 [No Abstract] [Full Text] [Related]
2. Advanced cancer risk similar with biennial vs. annual mammography in women aged 50 to 74. Printz C Cancer; 2013 Aug; 119(16):2949. PubMed ID: 23913402 [No Abstract] [Full Text] [Related]
3. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011. Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141 [TBL] [Abstract][Full Text] [Related]
4. Two-view digital breast tomosynthesis versus digital mammography in a population-based breast cancer screening programme (To-Be): a randomised, controlled trial. Hofvind S; Holen ÅS; Aase HS; Houssami N; Sebuødegård S; Moger TA; Haldorsen IS; Akslen LA Lancet Oncol; 2019 Jun; 20(6):795-805. PubMed ID: 31078459 [TBL] [Abstract][Full Text] [Related]
5. Controversies regarding mammography, breast self-examination, and clinical breast examination. Nelson AL Obstet Gynecol Clin North Am; 2013 Sep; 40(3):413-27. PubMed ID: 24021250 [TBL] [Abstract][Full Text] [Related]
6. Breast cancer screening with mammography. Hirsch BR; Lyman GH Curr Oncol Rep; 2011 Feb; 13(1):63-70. PubMed ID: 21108025 [TBL] [Abstract][Full Text] [Related]
7. Breast cancer subtype and screening sensitivity in the Quebec Mammography Screening Program. Perron L; Chang SL; Daigle JM; Vandal N; Theberge I; Diorio C; Lemieux J; Pelletier E; Brisson J J Med Screen; 2019 Sep; 26(3):154-161. PubMed ID: 30572782 [No Abstract] [Full Text] [Related]
8. Breast Cancer Risk Assessment Models and High-Risk Screening. Barke LD; Freivogel ME Radiol Clin North Am; 2017 May; 55(3):457-474. PubMed ID: 28411673 [TBL] [Abstract][Full Text] [Related]
9. Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk. Lee JM; Arao RF; Sprague BL; Kerlikowske K; Lehman CD; Smith RA; Henderson LM; Rauscher GH; Miglioretti DL JAMA Intern Med; 2019 May; 179(5):658-667. PubMed ID: 30882843 [TBL] [Abstract][Full Text] [Related]
10. Risk-based Breast Cancer Screening: Implications of Breast Density. Lee CI; Chen LE; Elmore JG Med Clin North Am; 2017 Jul; 101(4):725-741. PubMed ID: 28577623 [TBL] [Abstract][Full Text] [Related]
11. Breast cancer screening in young women. Desreux JAC Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():208-211. PubMed ID: 29804884 [TBL] [Abstract][Full Text] [Related]
12. Breast cancer screening controversies: who, when, why, and how? Chetlen A; Mack J; Chan T Clin Imaging; 2016; 40(2):279-82. PubMed ID: 26093511 [TBL] [Abstract][Full Text] [Related]
13. Test sensitivity of mammography and mean sojourn time over 40 years of breast cancer screening in Nijmegen (The Netherlands). Aarts A; Duffy SW; Geurts S; Vulkan DP; Otten J; Hsu CY; Chen T; Verbeek A; Broeders M J Med Screen; 2019 Sep; 26(3):147-153. PubMed ID: 30541383 [No Abstract] [Full Text] [Related]
14. Wise guidance and its challenges: the new Canadian recommendations on breast cancer screening. Korenstein D CMAJ; 2018 Dec; 190(49):E1432-E1433. PubMed ID: 30530609 [No Abstract] [Full Text] [Related]
15. The Complexity of Achieving the Promise of Precision Breast Cancer Screening. Haas JS J Natl Cancer Inst; 2017 Jan; 109(5):. PubMed ID: 28130476 [No Abstract] [Full Text] [Related]
16. Evidence to Support Screening Women in Their 40s. Ray KM; Price ER; Joe BN Radiol Clin North Am; 2017 May; 55(3):429-439. PubMed ID: 28411671 [TBL] [Abstract][Full Text] [Related]
17. Automated and Clinical Breast Imaging Reporting and Data System Density Measures Predict Risk for Screen-Detected and Interval Cancers: A Case-Control Study. Kerlikowske K; Scott CG; Mahmoudzadeh AP; Ma L; Winham S; Jensen MR; Wu FF; Malkov S; Pankratz VS; Cummings SR; Shepherd JA; Brandt KR; Miglioretti DL; Vachon CM Ann Intern Med; 2018 Jun; 168(11):757-765. PubMed ID: 29710124 [TBL] [Abstract][Full Text] [Related]
18. Estimation of the benefit and harms of including clinical breast examination in an organized breast screening program. Jiang H; Walter SD; Brown P; Raina P; Chiarelli AM Breast; 2019 Feb; 43():105-112. PubMed ID: 30544057 [TBL] [Abstract][Full Text] [Related]
19. Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey. Sardanelli F; Aase HS; Álvarez M; Azavedo E; Baarslag HJ; Balleyguier C; Baltzer PA; Beslagic V; Bick U; Bogdanovic-Stojanovic D; Briediene R; Brkljacic B; Camps Herrero J; Colin C; Cornford E; Danes J; de Geer G; Esen G; Evans A; Fuchsjaeger MH; Gilbert FJ; Graf O; Hargaden G; Helbich TH; Heywang-Köbrunner SH; Ivanov V; Jónsson Á; Kuhl CK; Lisencu EC; Luczynska E; Mann RM; Marques JC; Martincich L; Mortier M; Müller-Schimpfle M; Ormandi K; Panizza P; Pediconi F; Pijnappel RM; Pinker K; Rissanen T; Rotaru N; Saguatti G; Sella T; Slobodníková J; Talk M; Taourel P; Trimboli RM; Vejborg I; Vourtsis A; Forrai G Eur Radiol; 2017 Jul; 27(7):2737-2743. PubMed ID: 27807699 [TBL] [Abstract][Full Text] [Related]
20. Screening Mammography and Digital Breast Tomosynthesis: Controversies. Funaro K; Drukteinis J; Falcon S South Med J; 2017 Oct; 110(10):607-613. PubMed ID: 28973699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]